More Proteomics International Laboratories Ltd. news
Proteomics International Laboratories Ltd.ASX: PIQ

Diabetic Kidney Disease patent granted in Russia

Dec 18, 2016 at 10:46 PM EST · Issued by Proteomics International Laboratories Ltd.

Filed with ASX · Dec 18, 2016 at 10:46 PM EST · 2 pages · English

On 6ix: 6ix.com/news/diabetic-kidney-disease-patent-granted-in-russia

Proteomics International Laboratories Ltd. on 6ix

Earlier from Proteomics International Laboratories

  • PromarkerD shows improved predictive ability and robustnessDec 14, 2016
  • Proteomics completes $1.44 million Placement and offers SPPDec 1, 2016
  • Proteomics and Linear partner in testing and clinical trialsNov 14, 2016
  • PromarkerD test kit production deal signedNov 10, 2016
  • Appendix 4C - September 2016 Quarterly ReportOct 24, 2016

Later from Proteomics International Laboratories

  • Appendix 4C - December 2016 Quarterly ReportJan 24, 2017
  • Diabetic Kidney Disease Diagnostic Test Data PublishedFeb 7, 2017
  • Proteomics targets diabetic kidney disease in AsiaMar 20, 2017
  • Frost & Sullivan- PromarkerD diagnostic test world leadingMar 26, 2017
  • PromarkerD UpdateApr 3, 2017
All Proteomics International Laboratories news releases↗

Follow Proteomics International Laboratories into a list and get an email when it puts out news.

Follow Proteomics International Laboratories
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer